Michael Dukes
Publications by Year
Research Areas
Estrogen and related hormone effects, Angiogenesis and VEGF in Cancer, Advanced MRI Techniques and Applications, Menopause: Health Impacts and Treatments, Endometriosis Research and Treatment
Most-Cited Works
- A potent specific pure antiestrogen with clinical potential.(1991)
- ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration.(2002)
- → AZD2171: A Highly Potent, Orally Bioavailable, Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for the Treatment of Cancer(2005)709 cited
- → Novel 4-Anilinoquinazolines with C-7 Basic Side Chains: Design and Structure Activity Relationship of a Series of Potent, Orally Active, VEGF Receptor Tyrosine Kinase Inhibitors(2002)308 cited
- → Arimidex�: A potent and selective fourth-generation aromatase inhibitor(1994)257 cited
- ZD4190: an orally active inhibitor of vascular endothelial growth factor signaling with broad-spectrum antitumor efficacy.(2000)
- → The preclinical pharmacology of “Arimidex” (Anastrozole; ZD1033) — a potent, selective aromatase inhibitor(1996)89 cited
- → Effects of a non-steroidal pure antioestrogen, ZM 189,154, on oestrogen target organs of the rat including bones(1994)66 cited
- → Antiuterotrophic effects of a pure antioestrogen, ICI 182,780: magnetic resonance imaging of the uterus in ovariectomized monkeys(1992)61 cited
- → Dynamic contrast-enhanced MRI of vascular changes induced by the VEGF-signalling inhibitor ZD4190 in human tumour xenografts(2003)54 cited